QT
TEVA icon

Quantamental Technologies’s Teva Pharmaceuticals TEVA Stock Holding History

Quantamental Technologies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$184K Buy
+18,086
New +$168K 0.17% 227
2019
Q4 		– Sell
-13,633
Closed -$94K – 1249
2019
Q3 		$94K Buy
+13,633
New +$104K 0.03% 763
2019
Q2 		– Sell
-3,999
Closed -$63K – 1792
2019
Q1 		$63K Buy
+3,999
New +$70.5K 0.03% 784

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Quantamental Technologies's TEVA Position: Q3 2023 in Review

Quantamental Technologies opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2023: 18,086 shares worth $184K. The stake represents 0.17% of the portfolio and ranks #227 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in TEVA as recently as Q3 2019.

Quantamental Technologies first reported a position in TEVA in Q1 2019 and has held it in 3 quarters since. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Quantamental Technologies held 18,086 shares of Teva Pharmaceuticals worth $184K as of Q3 2023.
  • Teva Pharmaceuticals was a new Quantamental Technologies position in Q3 2023.
  • Teva Pharmaceuticals made up 0.17% of Quantamental Technologies's portfolio in Q3 2023, its #227 holding.
  • Quantamental Technologies first reported a position in Teva Pharmaceuticals in Q1 2019 and has held it in 3 quarters since.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.